Fox News hosts seem worried about the FDA's COVID vaccine approval — but can't get their stories straight

Fox News hosts seem worried about the FDA's COVID vaccine approval — but can't get their stories straight
Image via Screengrab.
Bank

Minutes after the FDA announced full approval for Pfizer's coronavirus vaccine Fox News ran a segment that kicked off with the host suggesting the approval was "rushed," only to have another host ask, "what took so long?"

The Fox News guest, former Trump testing czar Admiral Brett Giroir, immediately handed credit for the Pfizer vaccine to the Trump administration's Operation Warp Speed, despite Pfizer developing its vaccine without any support from the federal government (other than the federal government agreeing to purchase it.)

Last week Media Matters reported in a six week period this summer "nearly 60%" of Fox News' "vaccine segments included claims undermining or downplaying vaccinations."

Watch:


Understand the importance of honest news ?

So do we.

The past year has been the most arduous of our lives. The Covid-19 pandemic continues to be catastrophic not only to our health - mental and physical - but also to the stability of millions of people. For all of us independent news organizations, it’s no exception.

We’ve covered everything thrown at us this past year and will continue to do so with your support. We’ve always understood the importance of calling out corruption, regardless of political affiliation.

We need your support in this difficult time. Every reader contribution, no matter the amount, makes a difference in allowing our newsroom to bring you the stories that matter, at a time when being informed is more important than ever. Invest with us.

Make a one-time contribution to Alternet All Access, or click here to become a subscriber. Thank you.

Click to donate by check.

DonateDonate by credit card
Donate by Paypal
{{ post.roar_specific_data.api_data.analytics }}
@2022 - AlterNet Media Inc. All Rights Reserved. - "Poynter" fonts provided by fontsempire.com.